Merck Announces Third-Quarter 2017 Financial Results

Go back to Merck Announces Third-Quarter 2017 Financial Results

Merck (MRK) PT Lowered to $69 at Leerink Partners

October 30, 2017 7:49 AM EDT

Leerink Partners lowered its price target on Merck (NYSE: MRK) to $69.00 (from $70.00) while maintaining a Market Perform rating following results

Analyst Seamus Fernandez said the majority of the bottom-line beat came from other income and a lower-than-anticipated tax rate.

... More

Merck (MRK) Tops Q3 EPS by 8c, Lifts FY EPS Gudiance

October 27, 2017 6:46 AM EDT

(Updated - October 27, 2017 6:49 AM EDT)

Merck (NYSE: MRK) reported Q3 EPS of $1.11, $0.08 better than the analyst estimate of $1.03. Revenue for the quarter came in at $10.3 billion versus the consensus estimate of $10.55 billion.

Financial... More